Pain Management in Older Adults - Nonopioid First and Dose Adjustment

Key Points

• Untreated pain can cause immobility, delirium, sleep disruption, and loss of function.
• Use functional goals rather than a zero-pain target.
• Acetaminophen and topical therapies are often useful low-risk starting options.
• Systemic NSAIDs require caution because GI, renal, cardiovascular, and fluid risks rise with age.
• Neuropathic agents require renal dosing and monitoring for sedation or falls.
• Start opioids lower and titrate cautiously in frail opioid-naive adults.
• Regular opioid therapy generally requires constipation prevention.
• Avoid opioid-benzodiazepine combinations when possible.

Algorithm

1. Identify pain mechanism and rule out urgent causes.
2. Define a functional treatment goal.
3. Use nonpharmacologic and topical/local strategies when appropriate.
4. Choose nonopioid medication based on organ function and risks.
5. Add opioid therapy when pain severity and expected benefit justify it.
6. Reassess pain, function, cognition, gait, bowel function, and adverse effects.
7. Adjust for kidney/liver function and avoid high-risk drug combinations.
8. Refer for specialty or palliative support when pain remains refractory.

Clinical Synopsis & Reasoning

Pain assessment can be difficult when hearing, cognition, language, or dementia limits self-report, but self-report remains the preferred measure whenever possible. Ask about location, quality, timing, provoking factors, sleep, mood, mobility, and the functional goal the patient wants to regain. In cognitive impairment, use validated observational tools and caregiver input, looking for guarding, grimacing, vocalization, resistance to care, or change in activity. New focal pain requires diagnostic evaluation rather than automatic escalation of analgesics.

Nonpharmacologic therapy can include heat or cold, physical therapy, graded activity, strengthening, massage, cognitive-behavioral approaches, splinting, or targeted procedures depending on etiology. Acetaminophen is often useful for musculoskeletal pain when liver disease and cumulative dose are considered. NSAIDs can be effective but carry increased gastrointestinal, renal, fluid-retention, and cardiovascular risk in older adults; use the lowest effective dose for the shortest feasible duration and avoid or restrict them in high-risk patients. Topical NSAIDs can provide local benefit with less systemic exposure.

Neuropathic pain may respond to duloxetine, gabapentin, pregabalin, or selected other agents, but dose adjustment and adverse-effect review are important. Gabapentinoids can cause sedation and gait instability, particularly with opioids and renal impairment. Tricyclic antidepressants have anticholinergic and orthostatic effects that often limit their use in frail older adults. Opioids should be selected when expected benefit outweighs risk, starting at lower doses and titrating slowly while monitoring function, alertness, bowel function, and breathing.

Treatment Strategy & Disposition

Set a treatment goal such as walking to the bathroom, sleeping through the night, or participating in therapy rather than pursuing a zero-pain score. For acute severe pain, provide timely analgesia and reassess. If an opioid is needed, choose an agent appropriate to kidney and liver function, avoid meperidine, use lower starting doses in opioid-naive frail adults, and add constipation prophylaxis for regular use. Avoid combining opioids with benzodiazepines when possible because sedation and respiratory depression are additive. Naloxone should be considered for patients at elevated overdose risk.

For chronic pain, review benefit periodically. Continued opioid therapy should demonstrate meaningful improvement in pain or function without unacceptable harm. Screen for sedation, falls, confusion, constipation, endocrine effects, and problematic use. Dose escalation should not substitute for reassessing the diagnosis. Multimodal treatment can reduce reliance on any single drug. In advanced illness or cancer, higher opioid requirements may be appropriate and should not be withheld solely because of age when symptoms are otherwise uncontrolled.

Renal impairment changes opioid and adjuvant selection. Morphine metabolites and some gabapentinoids can accumulate. Fentanyl and selected other opioids have different renal profiles, but choice should follow clinical context and local expertise. Palliative care or pain specialists can help with difficult conversions, refractory symptoms, or interventional options. The aim is individualized relief with preservation of cognition and mobility whenever possible.

Epidemiology / Risk Factors

• Chronic pain becomes more prevalent with age and musculoskeletal disease.
• Cognitive impairment can lead to under-recognition of pain.
• Polypharmacy increases the risk of analgesic interactions.
• Frailty changes both pharmacokinetics and the consequences of sedation.

Investigations

Caution Medications

Pharmacology

Prognosis / Complications

• Multimodal therapy can improve function while limiting drug toxicity.
• Persistent severe pain can accelerate deconditioning and depression.
• Opioid benefit varies by pain mechanism and should be reassessed over time.
• Advanced illness may appropriately shift priorities toward symptom relief even when sedation risk increases.

Patient Education / Counseling

• Set realistic goals around activity, sleep, and comfort.
• Review safe use of acetaminophen and avoidance of duplicate products.
• Explain opioid constipation prevention and overdose warning signs.
• Avoid alcohol and unprescribed sedatives with opioids.
• Report new confusion, falls, black stools, reduced urine output, or excessive sleepiness.
• Store opioids securely and dispose of unused medication safely.

Notes

Pain treatment in older adults is a balance between two kinds of harm: medication toxicity and the consequences of untreated pain. Avoid therapeutic nihilism. A carefully titrated opioid can be safer than immobilizing pain in the right patient, while an unnecessary sedative combination can be more dangerous than the pain itself. Reassess after every meaningful change and judge success by what the patient can do and how safely they can do it.

References

1. American Geriatrics Society: 2023 AGS Beers Criteria — Link
2. American Geriatrics Society: Guidelines and Recommendations — Link